Completed PHASE3 INTERVENTIONAL 2-arm NCT01212549

Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma (IMCXvsCIMT)

Open Label, Randomized Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma of the Skin

Sponsor: University of Ioannina

Conditions Basal Cell Carcinoma

Interventions Cryoimmunotherapy Immunocryosurgery

Updated 5 times since 2017 Last updated: Aug 31, 2011 Started: Feb 28, 2009 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Basal Cell Carcinoma and is currently completed. University of Ioannina leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Ioannina

Data source: University of Ioannina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ioannina, Greece